Page last updated: 2024-10-22

amsacrine and Cancer of Pharynx

amsacrine has been researched along with Cancer of Pharynx in 1 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Research Excerpts

ExcerptRelevanceReference
"Although only a few patients with head and neck cancer have been included in broad phase II studies, several responses have been reported, but detailed data concerning responders are lacking."2.68A two-step reevaluation of high-dose amsacrine for advanced carcinoma of the upper aerodigestive tract: a pilot phase II study. ( Jelic, S; Jovanovic, V; Kovcin, V; Milanovic, N; Nikolic-Tomasevic, Z; Tomasevic, Z; Vlajic, M, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jelic, S1
Nikolic-Tomasevic, Z1
Kovcin, V1
Milanovic, N1
Tomasevic, Z1
Jovanovic, V1
Vlajic, M1

Trials

1 trial available for amsacrine and Cancer of Pharynx

ArticleYear
A two-step reevaluation of high-dose amsacrine for advanced carcinoma of the upper aerodigestive tract: a pilot phase II study.
    Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:5

    Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Carcinoma, Squamous Cell; Disease-Free Survival; Dose

1997